References
Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to “pseudomyxoma peritonei.” Am J Surg Pathol. 1995;19(12):1390–408.
Misdraji J, Carr NJ, Pai RK, Vang R. Pseudomyxoma peritonei. In: World Health organization classification of tumours 5th Edition: Female Genital Tumours. Lyon, France: IARC, 2020, pp 211-213.
Memon AA, Godbole C, Cecil T, et al. Overall survival is more closely associated with peritoneal than primary appendiceal pathological grade in pseudomyxoma peritonei with discordant pathology. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10994-z.
Choudry HA, Pai RK, Parimi A, et al. Discordant diagnostic terminology and pathologic grading of primary appendiceal mucinous neoplasms reviewed at a high-volume center. Ann Surg Oncol. 2019;26(8):2607–14. https://doi.org/10.1245/s10434-019-07447-z.
Al-Azzawi M, Misdraji J, van Velthuysen MF, et al. Acellular mucin in pseudomyxoma peritonei of appendiceal origin: what is adequate sampling for histopathology? J Clin Pathol. 2020;73(4):220–2. https://doi.org/10.1136/jclinpath-2019-206213.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Godbole, C., Memon, A.A. & Carr, N.J. ASO Author Reflections: Discordant Pathology in Pseudomyxoma Peritonei and Its Impact on Survival following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol 29, 2614–2615 (2022). https://doi.org/10.1245/s10434-021-11021-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-11021-x